RCT study for neuropsychological treatment of memory performance of patients with MCI and mild Alzheimer's disease: „Memory Improvement in MCI and AD (MIMA)

Not Applicable

• Conditions: F00; Mild cognitive disorder; F06.7; Dementia in Alzheimer disease

• Registration Number: DRKS00019070
• Lead Sponsor: Carl von Ossietzky Universität Oldenburg

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2019-11-11
• Study Completion: 2020-03-20
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting stopped after recruiting started
• Sex: All
• Target Recruitment: 14

Inclusion Criteria

Mini Mental Status Scores between 21 and 30

Exclusion Criteria

Geriatric Depression Scale Scores higher 5 exclude people from the study.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The study is finished after at least 32 patients participated in the study.<br><br>The primary outcome is defined by MMSE-Score and quality of life because they are widely accepted standard measures. The quality of life is measured with the SF-12 questionnaire.

Secondary Outcome Measures

Name	Time	Method
Die Studie wird beendet, wenn mindestens 32 Patienten ihre Teilnahme erfolgreich abgeschlossen haben.<br><br>The CERAD test battery and the digit span forward and backwards from the Wechsler-Memory Scale are used as secondary outcomes.